BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

Includes asymptomatic testing at community-based facilities to prevent widespread transmissions Regular testing for COVID-19, flu, RSV crucial for stayi...

May 26, 2022 | News

Hanmi Fine Chemical Launches 'high-tech CDMO' Business

10 billion KRW invested in Hanmi Fine Chemical facility expansion Hanmi Fine Chemical (hereinafter Hanmi FC) a subsidiary of Hanmi Pharmaceutic...

May 23, 2022 | News

A novel universal antiviral drug introduced in Korea

The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antiviral agent, developed ...

May 13, 2022 | News

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

During the BIO KOREA 2022, Dr. Brian H. Min, CEO of GenScript ProBio, introduced the development history of GenScript ProBio to the participants and o...

May 13, 2022 | News

iNtRON Biotechnology, Inc., Launches New Website

The parent company of iNtODEWORLD, Inc., iNtRON Biotechnology, Inc., ("iNtRON" or "Company") is thrilled to announce the launch of its new website,&nb...

May 10, 2022 | News

ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome

ExoCoBio Inc., one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims tha...

May 09, 2022 | News

Samsung Biologics Reports First Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results for t...

April 28, 2022 | News

Seegene unveils world's first commercialized '3 Ct' PCR assay

"Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, Mu...

April 27, 2022 | News

South Korea to advance treatments for rare pediatric diseases in Asian countries

As announced earlier (https://adgepharm.com/news/mar-22-2022/), Adge has secured a global license to RO269228, a clinical stage oral small molecule origina...

April 26, 2022 | News

Samsung Biologics completes full acquisition of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has completed the purchase of Biogen's stake in the Samsung Bioepis joint venture for USD $...

April 21, 2022 | News

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative

HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy by investing ...

April 13, 2022 | News

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...

April 07, 2022 | News

BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022

Initiated in 2006, BIO KOREA is the biggest bio-health convention in Asia that is dedicated to promoting the international standing of Korea's he...

April 07, 2022 | News

Samsung Biologics holds 11th Annual General Meeting of Shareholders

Five matters were presented and approved unanimously at this year's meeting, which included the approval of financial statement, appointment of directors, ...

March 29, 2022 | News

Stay Connected